These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21296616)

  • 41. Angiotensins and Their Receptors in Cardiac and Vascular Injury.
    Schmull S; Wang Z; Gao L; Lv J; Li J; Xue S
    Curr Hypertens Rev; 2016; 12(3):170-180. PubMed ID: 26931475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of angiotensin II in stem cell therapy of cardiac disease.
    Ahmadian E; Jafari S; Yari Khosroushahi A
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):702-11. PubMed ID: 26670032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The adipose renin-angiotensin system: role in cardiovascular disease.
    Thatcher S; Yiannikouris F; Gupte M; Cassis L
    Mol Cell Endocrinol; 2009 Apr; 302(2):111-7. PubMed ID: 19418627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of renin-angiotensin system and antitumor effect of ARB in prostate cancer].
    Uemura H; Hoshino K; Kubota Y
    Nihon Rinsho; 2011 Jun; 69 Suppl 5():155-9. PubMed ID: 22207962
    [No Abstract]   [Full Text] [Related]  

  • 45. Hormones and the neovascularization process: role of angiotensin II.
    Silvestre JS; Lévy BI
    EXS; 2005; (94):77-93. PubMed ID: 15617472
    [No Abstract]   [Full Text] [Related]  

  • 46. Functional analysis of cardiovascular renin-angiotensin system using a gain or loss of function approach.
    Morishita R; Aoki M; Ogihara T
    Hypertens Res; 2000 Mar; 23(2):137-41. PubMed ID: 10770260
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation.
    Lin CP; Lin FY; Huang PH; Chen YL; Chen WC; Chen HY; Huang YC; Liao WL; Huang HC; Liu PL; Chen YH
    Biomed Res Int; 2013; 2013():845037. PubMed ID: 23484163
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beyond the Paradigm: Novel Functions of Renin-Producing Cells.
    Steglich A; Hickmann L; Linkermann A; Bornstein S; Hugo C; Todorov VT
    Rev Physiol Biochem Pharmacol; 2020; 177():53-81. PubMed ID: 32691160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of the Renin-Angiotensin System on the Pathogeny and Pharmacotherapeutics of Neurodegenerative Diseases.
    Bild W; Vasincu A; Rusu RN; Ababei DC; Stana AB; Stanciu GD; Savu B; Bild V
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Endothelial progenitor cells: current issues on characterization and challenging clinical applications.
    Resch T; Pircher A; Kähler CM; Pratschke J; Hilbe W
    Stem Cell Rev Rep; 2012 Sep; 8(3):926-39. PubMed ID: 22095429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current research concerning the RAS in pancreatic stem cells.
    Leung PS
    Adv Exp Med Biol; 2010; 690():155-77. PubMed ID: 20700842
    [No Abstract]   [Full Text] [Related]  

  • 52. Implications of intracrine hormone action for physiology and medicine.
    Re RN
    Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H751-7. PubMed ID: 12578810
    [No Abstract]   [Full Text] [Related]  

  • 53. The reactive oxidative species-renin-angiotensin system link.
    Aviv A
    J Hypertens; 2002 Dec; 20(12):2357-8. PubMed ID: 12473857
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacological approach for drug repositioning against cardiorenal diseases.
    Zamami Y; Imanishi M; Takechi K; Ishizawa K
    J Med Invest; 2017; 64(3.4):197-201. PubMed ID: 28954981
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current research of the RAS in pancreatitis and pancreatic cancer.
    Leung PS
    Adv Exp Med Biol; 2010; 690():179-99. PubMed ID: 20700843
    [No Abstract]   [Full Text] [Related]  

  • 56. Radiolabeling of Angiotensin peptides.
    Speth RC; Harding JW
    Methods Mol Med; 2001; 51():275-95. PubMed ID: 21331724
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A preview of selected articles.
    Atkinson SP
    Stem Cells; 2021 May; 39(5):507-510. PubMed ID: 33860969
    [No Abstract]   [Full Text] [Related]  

  • 58. The antihypertensive action of C-phycocyanin is related to the prevention of angiotensin II-caused vascular dysfunction in chronic kidney disease.
    Tapia-Martínez JA; Centurión D; Franco-Colin M; Sánchez-López A; Beltran-Ornelas JH; Silva-Velasco DL; Franco PR; Blas-Valdivia V; Cano-Europa E
    Hypertens Res; 2024 Apr; 47(4):1024-1032. PubMed ID: 38238510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin II Promotes Skeletal Muscle Angiogenesis Induced by Volume-Dependent Aerobic Exercise Training: Effects on miRNAs-27a/b and Oxidant-Antioxidant Balance.
    Rodrigues LF; Pelozin BRA; da Silva Junior ND; Soci UPR; do Carmo EC; da Mota GFA; Cachofeiro V; Lahera V; Oliveira EM; Fernandes T
    Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circulating progenitor cells in hypertensive subjects: Effectiveness of a treatment with olmesartan in improving cell number and miR profile in addition to expected pharmacological effects.
    Mandraffino G; Aragona CO; Cairo V; Scuruchi M; Lo Gullo A; D'Ascola A; Alibrandi A; Loddo S; Quartuccio S; Morace C; Mormina E; Basile G; Saitta A; Imbalzano E
    PLoS One; 2017; 12(3):e0173030. PubMed ID: 28301500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.